Restoration of G to A mutated transcripts using the MS2-ADAR1 system

Area of Science:

• Molecular Biology
• Genetic Engineering
• Biotechnology

Background:

• Site-directed RNA editing (SDRE) shows potential for treating genetic disorders caused by point mutations.
• Current SDRE methods face challenges in achieving sufficient guide RNA levels for gene therapy.
• Stop codon mutations represent a class of genetic disorders that could benefit from gene editing interventions.

Purpose of the Study:

• To develop an efficient and scalable SDRE system for gene therapy applications.
• To engineer a novel RNA editing tool combining the ADAR1 deaminase domain with the MS2 system.
• To demonstrate the efficacy of the engineered system in correcting stop codon mutations in vitro.

Main Methods:

• Utilized an RNA binding MS2 coat protein fused with the ADAR1 deaminase domain.
• Engineered guide RNA molecules with MS2 stem-loops for enhanced targeting.
• Employed the CMV and U6 promoters for controlled expression of the editing components.
• Tested the system's ability to convert adenosine to inosine (recognized as guanosine) in target RNA sequences.

Main Results:

• The engineered ADAR1-MS2 system successfully targeted and edited specific adenosine residues in RNA.
• Demonstrated the conversion of adenosine to inosine (A-to-I) at targeted sites, effectively mimicking G-to-A mutations.
• Showcased the system's capability to correct engineered stop codons (TAG, TGA, TAA) in EGFP mRNA.

Conclusions:

• The developed SDRE system offers a promising strategy for efficient gene repair in genetic disorders.
• This approach facilitates the production of diverse protein isoforms from a single gene by restoring mutated RNA.
• Successful implementation of this technique could revolutionize gene therapy, enabling effective in vivo gene repair.